6/20
09:04 am
cyto
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management [Yahoo! Finance]
Medium
Report
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management [Yahoo! Finance]
6/20
09:01 am
cyto
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
Medium
Report
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
5/28
10:48 am
cyto
Altamira Therapeutics Provides Business Update [Yahoo! Finance]
Medium
Report
Altamira Therapeutics Provides Business Update [Yahoo! Finance]
5/28
10:31 am
cyto
Altamira Therapeutics Provides Business Update
Medium
Report
Altamira Therapeutics Provides Business Update
5/23
08:59 am
cyto
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal [Yahoo! Finance]
High
Report
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal [Yahoo! Finance]
5/23
08:47 am
cyto
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
Medium
Report
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
5/1
09:02 am
cyto
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation [Yahoo! Finance]
Low
Report
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation [Yahoo! Finance]
5/1
08:47 am
cyto
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
Medium
Report
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
4/24
10:13 am
cyto
Altamira reports publication of positive results from NASAR clinical trial with Bentrio [Seeking Alpha]
Medium
Report
Altamira reports publication of positive results from NASAR clinical trial with Bentrio [Seeking Alpha]
4/24
08:53 am
cyto
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal [Yahoo! Finance]
High
Report
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal [Yahoo! Finance]
4/24
08:47 am
cyto
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
High
Report
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
4/15
08:13 am
cyto
Diamond Equity Research Initiates Coverage on Altamira Therapeutics Ltd. (NASDAQ: CYTO) [Yahoo! Finance]
High
Report
Diamond Equity Research Initiates Coverage on Altamira Therapeutics Ltd. (NASDAQ: CYTO) [Yahoo! Finance]
4/12
08:36 am
cyto
Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
4/10
08:13 am
cyto
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results [Yahoo! Finance]
4/10
08:00 am
cyto
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
Medium
Report
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
4/4
09:00 am
cyto
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024 [Yahoo! Finance]
Medium
Report
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024 [Yahoo! Finance]
4/4
08:45 am
cyto
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
Medium
Report
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024